Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 52,902 - -
Change - -42.97% 0.25% -5.58% 13.3% 6.94% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 49,271 47,707 45,891
Change - -42.99% -1.65% -10.87% 13.8% 7.48% -3.17% -3.81%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 37.4x 28.6x 25.7x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 5.13x 4.47x 4.14x
PEG - 12.14x -5.79x 0x -0.6x 1x 0.9x 2.2x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.82x 7.12x 6.47x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 7.29x 6.42x 5.61x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 23.1x 19.9x 17.2x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 25x 21.6x 18.5x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 58x 29.6x 25.2x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.72% 3.37% 3.96%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.523 3.299 3.681
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,761 7,431 8,177
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,137 2,395 2,668
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,970 2,211 2,480
Net income 1 1,503 1,522 1,402 4,175 1,074 1,458 1,882 2,019
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,631 -5,195 -7,011
Reference price 2 129.55 74.61 76.25 74.03 85.25 94.44 94.44 94.44
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 576,400 - -
Announcement Date 26/1/22 31/1/23 6/2/24 11/2/25 10/2/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
36.38x7.29x23.05x-.--% 52.9B
36.06x6.09x23.28x0.26% 260B
37.21x7.05x22.09x0.62% 165B
51.2x12.41x26.62x-.--% 154B
16.67x3.37x10.92x-.--% 61.49B
20.86x2.49x12.59x2.42% 52.84B
48.66x12.03x26.52x-.--% 51.46B
35.36x7x23.77x0.57% 51.16B
83.48x7.91x24.03x-.--% 46.85B
58.38x9.42x33.52x-.--% 43.61B
Average 42.43x 7.51x 22.64x 0.39% 93.93B
Weighted average by Cap. 40.69x 7.60x 22.91x 0.35%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Edwards Lifesciences Corporation

Historical PBR trend

Valuation ratios - PBR - Edwards Lifesciences Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Edwards Lifesciences Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Edwards Lifesciences Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - Edwards Lifesciences Corporation
  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation